Distinct functionalities of bone morphogenetic protein antagonists during fracture healing in mice

Journal of Anatomy

Volumn 216, Issue 5, 2010, Pages 625-630

  Dean, Daniel B ^a   Watson, John T ^a   Jin, Wu ^a   Peters, Charlie ^b   Enders, J T ^b   Chen, Andrew ^a   Moed, Berton R ^a   Zhang, Zijun ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Antagonists; Bone; Bone morphogenetic proteins; Fracture; Rodent

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN AND ACTIVIN MEMBRANE BOUND INHIBITOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CHORDIN; DIFFERENTIAL SCREENING SELECTED GENE ABERRANT IN NEUROBLASTOMA; NOGGIN; OSTEOGENIC PROTEIN 1; PROTEIN CERBERUS; PROTEIN GREM1; PROTEIN INHIBITOR; PROTEIN RELATED TO DAN AND CERBERUS; SCLEROSTIN; SMAD6 PROTEIN; SMAD7 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MATURATION; BONE REMODELING; CALLUS; CONTROLLED STUDY; DOWN REGULATION; FEMUR FRACTURE; FRACTURE HEALING; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE SECTION; UPREGULATION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; FRACTURE HEALING; FRACTURES, BONE; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS AS TOPIC;

MUS; RODENTIA;

EID: 77953155768     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2010.01214.x     Document Type: Article

References (33)

1. Abe E. Function of BMPs and BMP antagonists in adult bone. Ann N Y Acad Sci 2006, 1068:41-53.
2. Aspenberg P, Jeppsson C, Economides AN. The bone morphogenetic proteins antagonist noggin inhibits membranous ossification. J Bone Miner Res 2001, 16:497-500.
3. Balesman W, Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 2002, 250:231-250.
4. Chang K, Weiss D, Suo J. Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries. Circulation 2007, 116:1258-1266.
5. Cook C, Vezina CM, Allgeier SH. Noggin is required for normal lobe patterning and ductal budding in the mouse prostate. Dev Biol 2007, 312:217-230.
6. Garrison KR, Donell S, Ryder J. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technol Assess 2007, 11:1-150. iii-iv
7. Gazzerro E, Canalis E. Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 2006, 7:51-65.
8. Gazzerro E, Minetti C. Potential drug targets within bone morphogenetic protein signaling pathways. Curr Opin Pharmacol 2007, 7:325-333.
9. Grotewold L, Plum M, Dildrop R. Bambi is coexpressed with Bmp-4 during mouse embryogenesis. Mech Dev 2001, 100:327-330.
10. Haque T, Hamade F, Alam N. Characterizing the BMP pathway in a wild type mouse model of distraction osteogenesis. Bone 2008, 42:1144-1153.
11. Higashihori N, Song Y, Richman JM. Expression and regulation of the decoy bone morphogenetic protein receptor BAMBI in the developing avian face. Dev Dyn 2008, 237:1500-1508.
12. Hiltunen A, Vuorio E, Aro HT. A standardized experimental fracture in the mouse tibia. J Orthop Res 1993, 11:305-312.
13. Jones AL, Bucholz RW, Bosse MJ. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 2006, 88:1431-1441.
14. Khanal A, Yoshioka I, Tominaga K. The BMP signaling and its Smads in mandibular distraction osteogenesis. Oral Dis 2008, 14:347-355.
15. Kingsley DM. The TGF-beta superfamily: new members, new receptors and new genetic tests of function in different organisms. Genes Dev 1994, 8:133-146.
16. Kloen P, Di Paola M, Borens O. BMP signaling components are expressed in human fracture callus. Bone 2003, 33:362-371.
17. Kwong FN, Richardson SM, Evans CH. Chordin knockdown enhances the osteogenic differentiation of human mesenchymal stem cells. Arthritis Res Ther 2008, 10:R65.
18. Marturano JE, Cleveland BC, Byrne MA. An improved murine femur fracture device for bone healing studies. J Biomech 2008, 41:1222-1228.
19. McMahon JA, Takada S, Zimmerman LB. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev 1998, 12:1438-1452.
20. Mills CD, Kincaid K, Alt JM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000, 164:6166-6173.
21. Mine N, Anderson RM, Klingensmith J. BMP antagonism is required in both the node and lateral plate mesoderm for mammalian left-right axis establishment. Development 2008, 135:2425-2434.
22. Nakamura N, Wakitani S, Nakayama J. Temporal and spatial expression profiles of BMP receptors and noggin during BMP-2 induced ectopic bone formation. J Bone Miner Res 2003, 18:1854-1862.
23. Niikura T, Hak DJ, Reddi AH. Global gene profiling reveals a downregulation of BMP gene expression in experimental atrophic nonunions compared to standard healing fractures. J Orthop Res 2006, 24:1463-1471.
24. Onichtchouk D, Chen YG, Dosch R. Silencing of TGF-beta signaling by the pseudoreceptor BAMBI. Nature 1999, 401:480-485.
25. Rosen V. BMP and BMP inhibitors in bone. Ann NY Acad Sci 2006, 1068:19-25.
26. Stabile H, Mitola S, Moroni E. Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood 2007, 109:1834-1840.
27. Tsiridis E, Upadhyay N, Giannoudis P. Molecular aspects of fracture healing: which are the important molecules? Injury 2007, 38(S1):S11-S25.
28. Tsuji K, Bandyopadhyay A, Harfe BD. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 2006, 38:1424-1428.
29. Tsuji K, Cox K, Bandyopadhyay A. BMP4 is dispensable for skeletogenesis and fracture-healing in the limb. J Bone Joint Surg Am 2008, 90(Suppl 1):14-18.
30. Vaibhav B, Nilesh P, Vikram S. Bone morphogenic protein and its application in trauma cases: a current concept update. Injury 2007, 38:1227-1235.
31. Wan DC, Pomerantz JH, Brunet LJ. Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation. J Biol Chem 2007, 282:26450-26459.
32. Wutzl A, Brozek W, Lernbass I. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation. J Biomed Mater Res (A) 2006, 77:75-83.
33. Xiao YT, Xiang LX, Shao JZ. Bone morphogenetic protein. Biochem Biophys Res Commun 2007, 362:550-553.